ICU sedation, delirium & recovery

Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial

Intensive Care MedPublished Randomised controlled trial

Primary resultResult — go to the resultMean difference 100.8 minutes 95% CI 38.2–163.4

Authors' conclusion

Among postoperative elective surgical patients admitted to HDU, low-dose non-titrated clonidine, compared to placebo, was associated with longer and subjectively better-quality sleep.

Study context

Population
Adult elective surgery high-dependency unit (HDU) patients in a single academic hospital80 analysed
Participants
83 patients
Comparison
Clonidine 0.3 μg/kg/h vs saline placebo on the night of surgery
  • Clonidinen = 39
  • Placebon = 41reference
Primary endpoint
Total sleep time measured using a consumer actigraphy/photoplethysmography device
Methodological detailsdouble-blind, placebo-controlled, parallel-group, pilot effectiveness, single-centre
  • Double-blind
  • Placebo-controlled
  • Parallel-group
  • Pilot effectiveness
  • Single-centre

Primary result

As reported in the abstract

Mean difference

100.8 minutes

95% CI 38.2–163.4

P = 0.002

By group

Clonidine vs Placebo
mean difference 100.8 minutes (95% CI 38.2–163.4); P = 0.002

Further findings

Subjective sleep quality

Clonidine patients reported better sleep overall

Delirium

Observed in one patient prior to study drug infusion
1
Delirium at the end of the study
0

Safety

Medication ceased due to bradycardia and hypotension · required no additional treatment — Clonidine
4 events

Safety outcomes

Not different between groups

Original publication

Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial. Intensive Care Med. Published 23 September 2024. doi:10.1007/s00134-024-07619-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.